When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Histoplasmosis

Last reviewed: 10 Feb 2026
Last updated: 03 Mar 2026

Summary

Definition

History and exam

Key diagnostic factors

  • exposure to fungal spores
  • risk factors that impair host defenses
  • fever
  • headache
  • dyspnea
  • dry or nonproductive cough
  • pleuritic chest pain
  • anorexia
  • productive cough
Full details

Other diagnostic factors

  • abdominal pain
  • fatigue
  • malaise
  • arthralgias
  • weight loss
  • hepatosplenomegaly
  • scattered crackles on chest auscultation
  • bronchial breathing on chest auscultation
  • distant breath sounds on chest auscultation
  • hemoptysis
  • meningitis-like symptoms
  • skin lesions
  • gastrointestinal symptoms
  • sepsis-like syndrome
Full details

Risk factors

  • exposure to fungus
  • emphysema
  • HIV infection
  • treatment with tumor necrosis factor (TNF)-alpha antagonists
  • treatment with corticosteroids
  • treatment with other immunosuppressants and biologic agents
  • primary immunodeficiency (especially those associated with T-cell impairment)
  • stem cell and solid organ transplant
  • graft-versus-host disease
Full details

Diagnostic investigations

1st investigations to order

  • chest x-ray
  • culture
  • antigen testing
  • serology (immunodiffusion precipitin test)
  • serology (complement fixation assay)
  • serology (enzyme immunoassay)
  • CT scan of chest
  • CBC
  • LFTs
Full details

Investigations to consider

  • tissue biopsy
Full details

Treatment algorithm

ACUTE

asymptomatic pulmonary disease (nonpregnant)

symptomatic pulmonary disease (nonpregnant)

chronic pulmonary disease (nonpregnant)

disseminated disease (nonpregnant)

mediastinal granuloma (nonpregnant)

mediastinal fibrosis (nonpregnant)

broncholithiasis (nonpregnant)

pericarditis (nonpregnant)

rheumatologic syndrome (nonpregnant)

meningoencephalitis (nonpregnant)

pregnant

Contributors

Authors

David L. Goldman, MD

Associate Professor

Pediatric Infectious Diseases

The Children's Hospital at Montefiore

Bronx

NY

Disclosures

DLG declares that he has no competing interests.

Philip Lee, Pharm D

Clinical Pharmacist for Pediatric Infectious Disease

The Children’s Hospital at Montefiore

Bronx

New York

Disclosures

PL declares that he has no competing interests.

Acknowledgements

Dr David L. Goldman and Dr Philip Lee would like to gratefully acknowledge Dr Zainab A. Malik, a previous contributor to this topic.

Peer reviewers

Kassem Hammoud, MD

Associate Professor

Division of Infectious Diseases

University of Kansas Health System

Kansas City

MI

Disclosures

KH declares that he has no competing interests.

Adriana M. Rauseo, MD

Assistant Professor of Medicine

Division of Infectious Diseases

Department of Internal Medicine

Washington University in St Louis

St Louis

MI

Disclosures

AMR declares that she has no competing interests.

Paul Roberts, MD

Assistant Professor

Family Medicine

Mayo Clinic

Jacksonville

FL

Disclosures

PR declares that he has no competing interests.

Janak Koirala, MD

Associate Professor of Medicine

Division of Infectious Diseases

Department of Internal Medicine

Southern Illinois University School of Medicine

Springfield

IL

Disclosures

JK declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Infectious Diseases Society of America. IDSA 2025 guideline update on the treatment of asymptomatic histoplasma pulmonary nodules (histoplasmomas) and mild or moderate acute pulmonary histoplasmosis in adults, children, and pregnant people. Mar 2025 [internet publication].Full text

Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74.Full text  Abstract

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and the Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: histoplasmosis. Oct 2024 [internet publication].Full text

Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Histoplasmosis images
  • Differentials

    • Community-acquired pneumonia
    • Pneumocystis jirovecii pneumonia (PCP)
    • Pulmonary tuberculosis
    More Differentials
  • Guidelines

    • IDSA 2025 guideline update on the treatment of asymptomatic histoplasma pulmonary nodules (histoplasmomas) and mild or moderate acute pulmonary histoplasmosis in adults, children, and pregnant people
    • Testing algorithms for fungal pneumonias
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer